by Jennifer P | Mar 7, 2021 | Canadian Regulatory, OTC Drugs
The deadline for the first step of Health Canada’s new risk evaluation for the presence of N-nitrosamine impurities in Canadian human pharmaceutical, biological and radiopharmaceutical products is fast approaching. This new Health Canada requirement for all Market...
by Jennifer P | May 1, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, U.S. Regulatory
Sterigenics, an international company who provides sterilization solutions for medical devices, pharmaceutical, commercial, and food industries, has shut down its plant in Willowbrook, Illinois. The recent shutdown, which took place in February 2019, was linked to the...
by Jennifer P | Apr 24, 2019 | Cosmetics, OTC Drugs, Research/Science/Technology, U.S. Regulatory
Amway, an American multi-level marketing company that sells health, beauty, and home care products, has approached a new take on improving their business before outsider digital technology disrupts it. They recently teamed up with Texas-based software company, Kony,...
by Jennifer P | Apr 17, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, OTC Drugs
Health Canada is working towards improving the way self-care products (cosmetics, NHPs, and non-prescription drugs) are regulated in Canada. These changes will be implemented via the “Self-Care Framework” to regulate low-risk self care products in the same way, and...
by Jennifer P | Mar 19, 2019 | Cosmetics, Research/Science/Technology
As environmental awareness increases, consumers are looking for products that are sustainable for a better future. This means buying cosmetics and personal care products that are packaged in materials that are not going to end up in landfills or contribute to...
Recent Comments